Kristin Bigos Lab

  • The Kristin Bigos Lab employs functional neuroimaging and pharmacogenetics to find novel drug targets, test possible therapeutic agents for brain disorders and study variability in response to psychiatric medications. Recent studies have focused on the effects of genetic variations on the response to medication in mental illnesses such as schizophrenia. We have also researched the effects of sex, race and smoking on exposure to the schizophrenia medication olanzapine.

    Research Areas: brain disorders, schizophrenia, mental illness, pharmacogenomics, neuroimaging

    Principal Investigator

    Kristin Bigos, Ph.D.